VEGA PROTEIN SNL to be Introduced for the First Time at CPhI & ICSE China 2018 Exhibition

From June 20 to 22, 2018, the 18th China International Pharmaceutical Industry Exhibition will be held at the Shanghai New Exhibition Center in Shanghai. It will not only reflect the progress of the Chinese pharmaceutical industry but also gather representatives from various sectors of the industry from around the world (pharmaceutical companies, developers, distributors, professional associations, etc.). European company IDEAL PHARMA PEPTIDE will be one of the participants of the event, showcasing its new innovative peptide complex – VEGA PROTEIN SNL.

About IDEAL PHARMA PEPTIDE

IDEAL PHARMA PEPTIDE (Germany) is a company focused on innovations in the bioindustry. Its high-tech developments have no analogs in the sports nutrition and dietary supplements market. The company develops innovative peptide complexes based on short peptides – unique combinations of 2-3-4 amino acids with targeted effects that influence gene expression, promote cell renewal, and protein synthesis.

The action of peptide complexes mainly depends on the group of peptide bioregulators they belong to. The company has already introduced innovative IPH complexes to the sports nutrition market, each with a carefully thought-out composition and its own specific specialization.

Peptide complexes from IDEAL PHARMA PEPTIDE represent the future, and their use today is an innovation. The absolute advantage of short peptides is their colossal efficiency, lack of allergic reactions, and side effects. They quickly penetrate into the bloodstream and transmit the necessary “information” from one cell to another to regulate the function of a specific gene, biochemical process, and organ. SNL peptide complexes have high biological activity and clinically proven effectiveness.